289 related articles for article (PubMed ID: 16596786)
1. Cannabinoid mechanisms of pain suppression.
Walker JM; Hohmann AG
Handb Exp Pharmacol; 2005; (168):509-54. PubMed ID: 16596786
[TBL] [Abstract][Full Text] [Related]
2. Spinal and peripheral mechanisms of cannabinoid antinociception: behavioral, neurophysiological and neuroanatomical perspectives.
Hohmann AG
Chem Phys Lipids; 2002 Dec; 121(1-2):173-90. PubMed ID: 12505699
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid 1 (CB1) receptor--pharmacology, role in pain and recent developments in emerging CB1 agonists.
Talwar R; Potluri VK
CNS Neurol Disord Drug Targets; 2011 Aug; 10(5):536-44. PubMed ID: 21631407
[TBL] [Abstract][Full Text] [Related]
4. [The cannabinoid system and pain: towards new drugs?].
Beltramo M
J Soc Biol; 2009; 203(1):99-106. PubMed ID: 19358815
[TBL] [Abstract][Full Text] [Related]
5. Recent data on cannabinoids and their pharmacological implications in neuropathic pain.
Coman OA; Paunescu H; Coman L; Badarau A; Fulga I
J Med Life; 2008; 1(4):365-75. PubMed ID: 20108515
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological actions of cannabinoids.
Pertwee RG
Handb Exp Pharmacol; 2005; (168):1-51. PubMed ID: 16596770
[TBL] [Abstract][Full Text] [Related]
7. Role of CB1 and CB2 cannabinoid receptors in the development of joint pain induced by monosodium iodoacetate.
La Porta C; Bura SA; Aracil-Fernández A; Manzanares J; Maldonado R
Pain; 2013 Jan; 154(1):160-174. PubMed ID: 23199705
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.
Davis MP
Expert Opin Investig Drugs; 2014 Aug; 23(8):1123-40. PubMed ID: 24836296
[TBL] [Abstract][Full Text] [Related]
9. Targeting the cannabinoid system for pain relief?
Chiou LC; Hu SS; Ho YC
Acta Anaesthesiol Taiwan; 2013 Dec; 51(4):161-70. PubMed ID: 24529672
[TBL] [Abstract][Full Text] [Related]
10. Endocannabinoid mechanisms of pain modulation.
Hohmann AG; Suplita RL
AAPS J; 2006 Nov; 8(4):E693-708. PubMed ID: 17233533
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoids ameliorate pain and reduce disease pathology in cerulein-induced acute pancreatitis.
Michalski CW; Laukert T; Sauliunaite D; Pacher P; Bergmann F; Agarwal N; Su Y; Giese T; Giese NA; Bátkai S; Friess H; Kuner R
Gastroenterology; 2007 May; 132(5):1968-78. PubMed ID: 17484889
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoids and Pain: Sites and Mechanisms of Action.
Starowicz K; Finn DP
Adv Pharmacol; 2017; 80():437-475. PubMed ID: 28826543
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain.
Guindon J; Hohmann AG
Br J Pharmacol; 2008 Jan; 153(2):319-34. PubMed ID: 17994113
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoids in depressive disorders.
Poleszak E; Wośko S; Sławińska K; Szopa A; Wróbel A; Serefko A
Life Sci; 2018 Nov; 213():18-24. PubMed ID: 30290188
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid analgesia.
Walker JM; Huang SM
Pharmacol Ther; 2002 Aug; 95(2):127-35. PubMed ID: 12182960
[TBL] [Abstract][Full Text] [Related]
16. The endocannabinoid-CB receptor system: Importance for development and in pediatric disease.
Fride E
Neuro Endocrinol Lett; 2004; 25(1-2):24-30. PubMed ID: 15159678
[TBL] [Abstract][Full Text] [Related]
17. Expression and function of cannabinoid receptors CB1 and CB2 and their cognate cannabinoid ligands in murine embryonic stem cells.
Jiang S; Fu Y; Williams J; Wood J; Pandarinathan L; Avraham S; Makriyannis A; Avraham S; Avraham HK
PLoS One; 2007 Jul; 2(7):e641. PubMed ID: 17653268
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoids in pancreatic cancer: correlation with survival and pain.
Michalski CW; Oti FE; Erkan M; Sauliunaite D; Bergmann F; Pacher P; Batkai S; Müller MW; Giese NA; Friess H; Kleeff J
Int J Cancer; 2008 Feb; 122(4):742-50. PubMed ID: 17943729
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid receptors and pain.
Pertwee RG
Prog Neurobiol; 2001 Apr; 63(5):569-611. PubMed ID: 11164622
[TBL] [Abstract][Full Text] [Related]
20. Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice.
Haller VL; Cichewicz DL; Welch SP
Eur J Pharmacol; 2006 Sep; 546(1-3):60-8. PubMed ID: 16919265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
